A Case-based Approach to RSV Disease

Slides:

Advertisements

Similar presentations

The Cost Effectiveness of RSV Prophylaxis: Using Decision Analysis to Build a Better Guideline Melony E. S. Sorbero, PhD, MS, MPH.

Advertisements

Immunization and RSV/Palivizumab Clinic Update Advances in preventative care for our pediatric population.

Bronchiolitis and Synagis. CONTINUITY CLINIC Pretest Which of the following children should receive RSV prophylaxis during RSV season? Which of the following.

Respiratory Syncytial Virus Prophylaxis The criteria

Insert Program or Hospital Logo Introduction The Respiratory Syncytial virus (RSV) was discovered in 1956 and has been since recognized as one of the most.

SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.

Immunoprophylaxis for Prevention of Severe RSV Bronchiolitis Ma. Teresa C. Ambat, MD Neonatology-TTUHSC11/21/2008.

Age appears to be a significant effect modifier of the impact of palivizumab on RSV hospitalization risk. Given the rapid decrease of RSV risk with increasing.

SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.

Paramyxoviruses Stanley I. Martin, MD Associate Professor Division of Infectious Diseases.

RESPIRATORY SYNCYTIAL VIRUS (RSV)

The seasonal prevalence of bronchiolitis caused by specific pathogens

Copyright © 2011 American Medical Association. All rights reserved.

CIC Study Questions September 23, 2016.

Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma

New Guidelines to Prevent SCD: What You Need to Know

Chronic Hepatitis C Virus Infection

Starting Strong: Initial Evaluation of the Patient With HCV

HCV: Who Should We Screen and Why?

HCV Infection in the United States: What Are We Dealing With?

Program Goals Overview of HIV Epidemic HIV and Communities of Color.

RSV Bronchiolitis.

Update on Clostridium difficile Infection

Hot Topics in Hemophilia Nursing

Chronic Idiopathic Urticaria

PAH Therapy Revisited.

Infectious Disease Following Kidney Transplant: Core Curriculum 2010

The State of Pneumococcal Disease Prevention

Time to Take Gout Seriously

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Initiating Pre-exposure Prophylaxis The PrEP Checklist

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Respiratory Syncytial Virus (RSV) Hospitalizations in Infants and the Results of the Anderson et al. (SENTINEL1) Study,

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Optimizing Outcomes and Managing Adverse Events in CLL

Optimizing Frontline Care for Older Patients With Multiple Myeloma

Maternal Pertussis vaccination: Giving Newborns a head start

Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab Christelle Kassis,

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

Virological and clinical characterization of respiratory infections in children attending an emergency department during the first autumn-winter circulation.

Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.

Aspirin and Cardioprevention in 2018

CMV in the HSCT Recipient

IBD Increases Risk for Vaccine-Preventable Diseases

New Strategies to Reduce HF Readmissions

Managing Age-Related Clinical Issues in Hemophilia

Human metapneumovirus infection among children in Taiwan: a comparison of clinical manifestations with other virus-associated respiratory tract infections

Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay P. Jokela,

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Research and cardiopulmonary disease in Down syndrome: opportunities for therapeutic leverage. Research and cardiopulmonary disease in Down syndrome: opportunities.

Clinical manifestations of respiratory syncytial virus (RSV).

Transmission of respiratory syncytial virus at the paediatric intensive-care unit: a prospective study using real-time PCR A.C. van de Pol, J.W.A. Rossen,

Prospective evaluation of a dot-blot enzyme immunoassay (Directigen RSV) for the antigenic detection of respiratory syncytial virus from nasopharyngeal.

Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.

Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012 J. Ambrosioni,

Interference between respiratory syncytial virus and rhinovirus in respiratory tract infections in children S. Karppinen, L. Toivonen, L. Schuez-Havupalo,

Selecting Treatment Approaches in Hemophilia

R. Slinger, I. Moldovan, N. Barrowman, F. Chan

The prevalence of penicillin-non-susceptible Streptococcus pneumoniae among children aged < 5 years correlates with the biannual epidemic activity of.

Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer

L. Fuenzalida, J. Fabrega, S. Blanco, M. del Mar Martinez, C. Prat, M

HAE Prophylaxis.

Pulmonary Arterial Hypertension and Hospitalizations

Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.

My PAH Patient.

Etiology of acute respiratory infections in children.

Evidence-based management of bronchiolitis.

Navigating the Journey

Presentation transcript:

A Case-based Approach to RSV Disease

Learning Objectives

Respiratory Syncytial Virus (RSV)

RSV Morbidity and Mortality

Case 1 (cont)

Clinical Presentation

Clinical Presentation (cont)

Supportive Care

Supportive Care (cont)

Supportive Care (cont)

Supportive Care (cont)

Supportive Care (cont)

Case Conclusion

Case 2

Risk Factors for RSV Infection

Risk Factors for Severe RSV Diseasea,b

RSV Prophylaxis

RSV Prophylaxis (cont)

Palivizumab AAP Recommendations Prematurity

Palivizumab AAP Recommendations CHD

Palivizumab AAP Recommendations CLD

Palivizumab AAP Recommendations (cont)

Palivizumab AAP Recommendations Immunosuppression

Case 2 (cont)

Other Preventative Measures

Control of Healthcare-Associated Infection

RSV Transmissiona

Closing Remarks

Abbreviations

References

References (cont)